Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PLAGL1 | hg38_v1_chr6_-_144064511_144064608 | 0.33 | 6.1e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr21_+_46098102 Show fit | 7.08 |
ENST00000300527.9
ENST00000310645.9 |
collagen type VI alpha 2 chain |
|
chr22_+_22409755 Show fit | 5.39 |
ENST00000390299.2
|
immunoglobulin lambda variable 1-40 |
|
chr16_+_1240698 Show fit | 5.18 |
ENST00000561736.2
ENST00000338844.8 ENST00000461509.6 |
tryptase alpha/beta 1 |
|
chr16_-_1230089 Show fit | 5.11 |
ENST00000612142.1
ENST00000606293.5 |
tryptase beta 2 |
|
chr3_+_13549117 Show fit | 4.87 |
ENST00000404922.8
|
fibulin 2 |
|
chr16_+_176659 Show fit | 4.64 |
ENST00000320868.9
ENST00000397797.1 |
hemoglobin subunit alpha 1 |
|
chr18_+_79400274 Show fit | 4.60 |
ENST00000545796.5
ENST00000318065.9 ENST00000592223.5 ENST00000329101.8 ENST00000586434.1 |
nuclear factor of activated T cells 1 |
|
chr3_-_71785167 Show fit | 4.49 |
ENST00000353065.7
|
prokineticin 2 |
|
chr11_-_64744317 Show fit | 4.45 |
ENST00000419843.1
ENST00000394430.5 |
RAS guanyl releasing protein 2 |
|
chr22_-_41926791 Show fit | 4.40 |
ENST00000291232.5
|
TNF receptor superfamily member 13C |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 64.5 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.4 | 57.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 43.9 | GO:0042119 | neutrophil activation(GO:0042119) |
0.4 | 36.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 36.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 26.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.7 | 21.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.8 | 16.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.9 | 15.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 12.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 76.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 73.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 56.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
1.1 | 54.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 44.4 | GO:0016604 | nuclear body(GO:0016604) |
0.4 | 44.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 40.3 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 36.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.2 | 31.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.3 | 26.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 104.1 | GO:0003823 | antigen binding(GO:0003823) |
1.0 | 71.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 65.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 60.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 30.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 21.8 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 21.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 20.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 18.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 18.1 | GO:0001047 | core promoter binding(GO:0001047) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 54.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 39.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 36.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 28.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 27.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 25.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 25.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 24.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 24.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 21.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 68.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 26.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.2 | 24.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 20.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 20.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 18.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 16.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 16.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.4 | 16.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 15.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |